Security record · archived quarter
JANX
Janux Therapeutics, Inc. · Healthcare · Biotechnology
12Tracked holders
0Δ holders
25.28MShares held
$583.88MReported value
+1New positions
−1Exits
Momentum inputs (comparable managers): holder breadth 0.0% · share flow +8.7% · net new positions 0.0% · formula
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2025
Ownership over time
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 77 | 0 | 35.14M | $539.55M | +6 | −6 |
| Q1 2026 | 80 | +4 | 31.30M | $434.70M | +12 | −8 |
| Q4 2025 | 75 | +1 | 36.09M | $498.13M | +1 | n/a |
| Q3 2025 | 15 | 0 | 27.21M | $664.97M | n/a | n/a |
| Q2 2025 | 12 | 0 | 25.28M | $583.88M | +1 | −1 |
| Q1 2025 | 9 | -2 | 8.77M | $236.76M | n/a | −2 |
| Q4 2024 | 11 | 0 | 8.88M | $475.25M | +1 | −1 |
| Q3 2024 | 10 | +1 | 4.53M | $205.89M | +1 | n/a |
| Q2 2024 | 9 | n/a | 5.15M | $215.67M | n/a | n/a |
Who holds it · Q2 2025
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Fidelity (FMR) ✦ | 8.89M | n/a | $205.33M | 0.0% | n/c | 1 | SEC ↗ ×5 |
| 2 | BlackRock ✦ (passive) | 3.40M | n/a | $78.61M | 0.0% | n/c | 1 | SEC ↗ ×13 |
| 3 | Adage Capital Partners ✦ | 2.52M | -30.9% | $58.33M | 0.1% | ▼ Trim | 5 | SEC ↗ |
| 4 | The Vanguard Group ✦ (passive) | 2.19M | n/a | $50.58M | 0.0% | n/c | 1 | SEC ↗ ×5 |
| 5 | Point72 Asset Management ✦ | 2.14M | +469.2% | $49.52M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 6 | T. Rowe Price ✦ | 1.79M | +28.8% | $41.43M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 7 | State Street Global Advisors ✦ (passive) | 1.39M | +1.2% | $32.07M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 8 | Citadel Advisors ✦ | 1.23M | +74.2% | $28.44M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 9 | Geode Capital Management ✦ (passive) | 902.31K | +15.6% | $20.85M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 10 | Wellington Management ✦ | 492.36K | +25.1% | $11.37M | 0.0% | ▲ Add | 5 | SEC ↗ ×7 |
| 11 | Millennium Management ✦ | 214.36K | +160.6% | $4.95M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 12 | Two Sigma Investments ✦ | 104.38K | New | $2.41M | 0.0% | New | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| Two Sigma Investments | $2.41M | 0.0% |
Exited
| AQR Capital Management | $262,359 | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 188 holders, 59.36M shares, $809.28M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
Frequently co-owned
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Provenance: Ownership from parsed 13F common-stock positions (tracked universe, comparable sets for changes); insider rows from Forms 3/4/5; stakes from Schedules 13D/13G; every filing links to its original on SEC EDGAR.
Reporting period: Q2 2025 ·
Methodology ·
Get this via the API